Showing Results for
- Academic Journals (39)
Search Results
- 39
Academic Journals
- 39
- Search Terms:
- 1From: Nature Biotechnology. (Vol. 22, Issue 1) Peer-ReviewedAuthor(s): Claudia Orellana [1] Alvaro DÃaz, Chile's deputy economy minister, presented the country's national policy, called "Biotechnology as a tool for development and wellbeing," in a ceremony attended by...
- 2From: Nature Biotechnology. (Vol. 22, Issue 1) Peer-ReviewedAuthor(s): Tom Jacobs [1] Each New Year, the financial media praise and blame 12-month results for stocks, mutual funds, bonds and Tony Blair futures. Biotech investors may well pop a few corks, with the AMEX...
- 3From: Nature Biotechnology. (Vol. 22, Issue 1) Peer-ReviewedAuthor(s): Jeffrey L. Fox [1] Cardinal Renato Martino and other key Vatican officials seem poised to endorse the use of genetically modified (GM) crops. However, by the end of a seminar, "GMO: threat or hope," convened...
- 4From: Nature Biotechnology. (Vol. 22, Issue 1) Peer-ReviewedKlausner investigated The US House of Representatives' Subcommittee on Oversight and Investigations, which brought down the university presidencies of Donald Kennedy and David Baltimore, have set their sights on...
- 5From: Nature Biotechnology. (Vol. 22, Issue 1) Peer-ReviewedAuthor(s): Rafael Rangel-Aldao [1] To the editor: Last summer, a meeting of the United Nations Organization for Industrial Development (UNIDO, Vienna, Austria) [1] stated that biotechnology can bring to the Latin...
- 6From: Nature Biotechnology. (Vol. 22, Issue 1) Peer-ReviewedAuthor(s): Aaron Bouchie [1] The use of biomarkers in clinical trials is slowly becoming a reality that the US Food and Drug Administration (FDA; Rockville, MD, USA) has begun to recognize. But standards need to be...
- 7From: Nature Biotechnology. (Vol. 22, Issue 1) Peer-ReviewedMyriad Genetics (Salt Lake City, UT, USA) has elected Robert S. Attiyeh , formerly CFO and senior vice president, finance and corporate development at Amgen, to its board of directors. In addition, Myriad has named Dale...
- 8From: Nature Biotechnology. (Vol. 22, Issue 1) Peer-ReviewedAuthor(s): Sue Pearson [1]; Hepeng Jia [1]; Keiko Kandachi [1] China became the first country to approve the commercial production of a gene therapy, and it is due to hit the market in early January. Despite technical...
- 9From: Nature Biotechnology. (Vol. 22, Issue 1) Peer-ReviewedAuthor(s): Emma Dorey [1] The Nasdaq Stock Market (New York), the world's largest electronic stock market, added 55 securities to its biotechnology index on November 24, bringing to 129 the total number of companies...
- 10From: Nature Biotechnology. (Vol. 22, Issue 1) Peer-ReviewedAuthor(s): Itsuki Shimbo (corresponding author) [1]; Rie Nakajima [2]; Shigeyuki Yokoyama [3]; Koichi Sumikura [4] At a conference held in Austria [1], the European Patent Office (EPO; Munich, Germany), United States...
- 11From: Nature Biotechnology. (Vol. 22, Issue 1) Peer-ReviewedAuthor(s): Karl Thiel [1] A US government document released in June 2000 warned of "a growing menace to all people [1]." The reference was not to terrorism or foreign dictators, but to the increasing prevalence of...
- 12From: Nature Biotechnology. (Vol. 22, Issue 1) Peer-ReviewedAuthor(s): Joseph Becker [1] Since Novartis' (Basel, Switzerland) imatinib mesylate (Gleevec) was hailed as a breakthrough in cancer treatment, other compounds that specifically target protein kinases have found...
- 13From: Nature Biotechnology. (Vol. 22, Issue 1) Peer-ReviewedAuthor(s): Steven H Strauss [1]; Stephen P DiFazio [2] Dangerous Liaisons? When Cultivated Plants Mate with Their Wild Relatives by Norman C.Ellstrand The Johns Hopkins University Press, 2003 268 pp. , $ 65 Crops...
- 14From: Nature Biotechnology. (Vol. 22, Issue 1) Peer-ReviewedThe clouds finally started to lift in 2003. Biotech stocks did well, rising more than the market as a whole, and there was a noticeable increase in merger and acquisitions activity, though the consolidation that analysts...
- 15From: Nature Biotechnology. (Vol. 22, Issue 1) Peer-ReviewedAuthor(s): Sungjee Kim [1, 6]; Yong Taik Lim [2, 5, 6]; Edward G Soltesz [3]; Alec M De Grand [2]; Jaihyoung Lee [2]; Akira Nakayama [2]; J Anthony Parker [4]; Tomislav Mihaljevic [3]; Rita G Laurence [3]; Delphine M Dor...
- 16From: Nature Biotechnology. (Vol. 22, Issue 1) Peer-ReviewedAuthor(s): Ainslie B Parsons [1, 2]; Renée L Brost [2]; Huiming Ding [2]; Zhijian Li [1, 2]; Chaoying Zhang [3]; Bilal Sheikh [2]; Grant W Brown [3]; Patricia M Kane [4]; Timothy R Hughes [1, 2]; Charles Boone...
- 17From: Nature Biotechnology. (Vol. 22, Issue 1) Peer-ReviewedAuthor(s): Sue Pearson 1 2 3, Hepeng Jia 1 2 3, Keiko Kandachi 1 2 3 Author Affiliations: (1) Joint reporting from Sue Pearson, Hitchin, UK (3) Keiko Kandachi, Tokyo, (2) Hepeng Jia, Beijing, China became the...
- 18From: Nature Biotechnology. (Vol. 22, Issue 1) Peer-ReviewedAuthor(s): Shreefal Mehta [1] The university has been slowly changing from ivory tower to economic engine. Publicly funded research organizations are becoming increasingly adept at protecting intellectual property...
- 19From: Nature Biotechnology. (Vol. 22, Issue 1) Peer-ReviewedAuthor(s): Sabine Louët [1] A report presented to the UK government and published on November 17 proposes to streamline clinical trials offered through the country's health system, the National Health Service (NHS;...
- 20From: Nature Biotechnology. (Vol. 22, Issue 1) Peer-ReviewedLab automation Reagent dispenser Bio-Tek Instruments' [mu]Fill line of automated bulk reagent dispensers has added a 24-well microplate format. [mu]Fill incorporates a microprocessor-controlled syringe pump for...